Bariatric-induced microbiome changes alter MASLD development in association with changes in the innate immune system

By sjmartinez • August 27, 2024

Shera S, Katzka W, Yang JC, Chang C, Arias-Jayo N, Lagishetty V, Balioukova A, Chen Y, Dutson E, Li Z, Mayer EA, Pisegna JR, Sanmiguel C, Pawar S, Zhang D, Leitman M, Hernandez L, Jacobs JP, Dong TS. Bariatric-induced microbiome changes alter MASLD development in association with changes in the innate immune system. Front Microbiol. 2024 Aug 9;15:1407555. doi: 10.3389/fmicb.2024.1407555. PMID: 39184030; PMCID: PMC11342267.

Tags: Clinical Nutrition, Digestive Diseases, fecal transplant, host innate immune system, metastatic dysfunction-associated steatotic liver disease, microbiome, Obesity, Post Doc, Publications, Veterans Administration

Response to the Letter to the Editor by Bett et al

Almandoz JP, Wadden TA, Tewksbury C, Apovian CM, Fitch A, Ard JD, Li Z, Richards J, Butsch WS, Jouravskaya I, Vanderman KS, Neff LM. Response[...]

Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity

Mechanick JI, Butsch WS, Christensen SM, Hamdy O, Li Z, Prado CM, Heymsfield SB. Strategies for minimizing muscle loss during use of incretin-mimetic drugs for[...]

Aspirin but not statins is inversely related to gastric cancer with a duration-risk effect: Results from the Stomach Cancer Pooling Project Consortium

Pastorino R, Pires Marafon D, Sassano M, Hoxhaj I, Pelucchi C, Liao LM, Rabkin CS, Sinha R, Lunet N, Morais S, Zaridze D, Maximovich D,[...]